Class II · Moderate risk
Ritussin DM Double Strength
cGMP Deviations: Products may have microbial contamination.
FDA Drug Recalls
1,563 recalls, newest first
Class II · Moderate risk
Preferred Plus Pharmacy Iron Elixir Ferrous Sulfate
cGMP Deviations: Products may have microbial contamination.
Class II · Moderate risk
Gericare Iron Supplement Elixir Ferrous Sulfate
cGMP Deviations: Products may have microbial contamination.
Class II · Moderate risk
Gericare Diocto Liquid Docusate Sodium Stool Softener
cGMP Deviations: Products may have microbial contamination.
Class II · Moderate risk
Ritussin DM Children & Adults
cGMP Deviations: Products may have microbial contamination.
Class II · Moderate risk
Diphenhydramine Oral Liquid Alcohol Free
cGMP Deviations: Products may have microbial contamination.
Class II · Moderate risk
Zileuton Extended-Release Tablets
Failed Dissolution Specifications: Out of specification result for dissolution.
Class II · Moderate risk
ZYFLO CR (zileuton)
Failed Dissolution Specifications: Out of specification result for dissolution.
Class II · Moderate risk
Trisodium Citrate 0.5% CRRT SOLUTION. RX Only. Rx # specific and…
Lack of sterility assurance.
Class II · Moderate risk
Memorial Central TPN. Rx Only
Lack of sterility assurance.
Class II · Moderate risk
Sn-Pyrophosphate Kit
Lack of Processing Controls.
Class II · Moderate risk
Sn-Tetrofosmin Kit 5.0 mL
Lack of Processing Controls.
Class II · Moderate risk
Sn-DTPA Kit 10 mg
Lack of Processing Controls.
Class II · Moderate risk
Sn-d
Lack of Processing Controls.
Class II · Moderate risk
Sulfur Colloid Reaction Vial 1.0 mL
Lack of Processing Controls.
Class II · Moderate risk
Sn-Mertiatide Kit
Lack of Processing Controls.
Class II · Moderate risk
Sn-DMSA solution
Lack of Processing Controls.
Class II · Moderate risk
Pentreotide
Lack of Processing Controls.
Class I · High risk
Pecgen DMX Cough Suppressant Expectorant
Labeling: Incorrect Instructions; The product has been found to provide incorrect dosage information on its label due to a typographical error. The drug facts label incorrectly states children 6 to under 2 years of age, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or directed by physician. The label should state children 6 to under 12, 1 teaspoonful every 4 hours, not to exceed 4 teaspoonfuls in 24 hours or as directed by physician. Additionally, the label does not advise consumers to consult a doctor for children under 2 years of age.
Class II · Moderate risk
Trimix 30mg/1 mg/10mcg/mL
Lack of Sterility Assurance.
Class II · Moderate risk
Testosterone Cypionate 200 mg/mL
Lack of Sterility Assurance.
Class II · Moderate risk
Testosterone Cyp/Pro 95/5%
Lack of Sterility Assurance.
Class II · Moderate risk
Testosterone 200 mg/mL
Lack of Sterility Assurance.
Class II · Moderate risk
Sermorelin/GHRP-2 &6
Lack of Sterility Assurance.
Class II · Moderate risk
Sermorelin/GHRP-2 &6
Lack of Sterility Assurance.